Crewe Advisors’s Genpact G Stock Holding History

Crewe Advisors’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9	Closed	-$397	–	995
2025 Q2	$397	Hold	9	–	–	﹤0.01%	667
2025 Q1	$454	Hold	9	–	–	﹤0.01%	633
2024 Q4	$387	Buy	+9	New	+$380	﹤0.01%	585
2023 Q1	–	Sell	-65	Closed	-$3.01K	–	907
2022 Q4	$3.01K	Sell	65 -289	-82%	-$13.1K	﹤0.01%	771
2022 Q3	$15K	Buy	354 +72	+26%	+$3.31K	﹤0.01%	547
2022 Q2	$12K	Buy	+282	New	+$12K	﹤0.01%	552

Other funds holding G

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Crewe Advisors's G Position: Q3 2025 in Review

Crewe Advisors sold out of Genpact (G) in Q3 2025, closing a stake of 9 shares — an estimated $397 sold.

Crewe Advisors first reported a position in G in Q2 2022 and held it in 6 quarters. The position peaked at $15K in Q3 2022. 493 funds tracked by Wall St. Rank hold G as of Q3 2025.

Crewe Advisors reported no remaining Genpact position as of Q3 2025 after selling out during the quarter.
Crewe Advisors sold 9 Genpact shares in Q3 2025, an estimated $397.
Crewe Advisors first reported a position in Genpact in Q2 2022 and held it in 6 quarters.
Crewe Advisors's Genpact position peaked at $15K in Q3 2022.
493 funds tracked by Wall St. Rank held Genpact as of Q3 2025.

Based on Crewe Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.